Zyklophin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Zyklophin == | |||
[[File:Zyklophin.svg|thumb|right|Chemical structure of Zyklophin]] | |||
Zyklophin | '''Zyklophin''' is a synthetic peptide that acts as a selective antagonist of the [[kappa opioid receptor]] (KOR). It is used primarily in research settings to study the role of kappa opioid receptors in various physiological and pathological processes. | ||
== | == Chemical Structure == | ||
Zyklophin is a | Zyklophin is a cyclic peptide, which means its amino acid sequence forms a closed loop. This cyclic structure is crucial for its stability and activity as a kappa opioid receptor antagonist. The chemical structure of Zyklophin is depicted in the image to the right. | ||
== | == Mechanism of Action == | ||
Zyklophin | Zyklophin functions by binding to the kappa opioid receptor, a type of [[G protein-coupled receptor]] (GPCR) found in the [[central nervous system]] and other tissues. By blocking the action of endogenous kappa opioid peptides, Zyklophin can modulate pain perception, mood, and other physiological responses. | ||
== | == Research Applications == | ||
Zyklophin is primarily used in [[preclinical research]] to explore the role of kappa opioid receptors in various conditions, including: | |||
== | * [[Pain management]]: Investigating the potential of KOR antagonists in treating chronic pain. | ||
* [[Depression]] and [[anxiety]]: Studying the effects of KOR antagonism on mood disorders. | |||
* [[Addiction]]: Understanding the involvement of kappa opioid receptors in substance use disorders. | |||
== Pharmacokinetics == | |||
As a peptide, Zyklophin is not orally bioavailable and is typically administered via injection in research studies. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are subjects of ongoing research to optimize its use in experimental settings. | |||
== Safety and Toxicity == | |||
While Zyklophin is a valuable tool in research, its safety profile in humans is not well-established, as it is not intended for clinical use. Studies in animal models are conducted to assess its potential toxicological effects. | |||
== Related Pages == | |||
* [[Kappa opioid receptor]] | * [[Kappa opioid receptor]] | ||
* [[Opioid receptor]] | * [[Opioid receptor]] | ||
* [[Peptide]] | * [[Peptide synthesis]] | ||
* [[G protein-coupled receptor]] | |||
[[Category:Peptides]] | [[Category:Peptides]] | ||
[[Category:Opioid antagonists]] | [[Category:Opioid receptor antagonists]] | ||
[[Category:Research | [[Category:Research tools]] | ||
Latest revision as of 03:42, 13 February 2025
Zyklophin[edit]
Zyklophin is a synthetic peptide that acts as a selective antagonist of the kappa opioid receptor (KOR). It is used primarily in research settings to study the role of kappa opioid receptors in various physiological and pathological processes.
Chemical Structure[edit]
Zyklophin is a cyclic peptide, which means its amino acid sequence forms a closed loop. This cyclic structure is crucial for its stability and activity as a kappa opioid receptor antagonist. The chemical structure of Zyklophin is depicted in the image to the right.
Mechanism of Action[edit]
Zyklophin functions by binding to the kappa opioid receptor, a type of G protein-coupled receptor (GPCR) found in the central nervous system and other tissues. By blocking the action of endogenous kappa opioid peptides, Zyklophin can modulate pain perception, mood, and other physiological responses.
Research Applications[edit]
Zyklophin is primarily used in preclinical research to explore the role of kappa opioid receptors in various conditions, including:
- Pain management: Investigating the potential of KOR antagonists in treating chronic pain.
- Depression and anxiety: Studying the effects of KOR antagonism on mood disorders.
- Addiction: Understanding the involvement of kappa opioid receptors in substance use disorders.
Pharmacokinetics[edit]
As a peptide, Zyklophin is not orally bioavailable and is typically administered via injection in research studies. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are subjects of ongoing research to optimize its use in experimental settings.
Safety and Toxicity[edit]
While Zyklophin is a valuable tool in research, its safety profile in humans is not well-established, as it is not intended for clinical use. Studies in animal models are conducted to assess its potential toxicological effects.
